MedTrace Logo

Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates

NCT02518126 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-08-07

No results posted yet for this study

Summary

To see if there is a relationship between the level of LIF in IUGR fetuses and compared to the level of LIF in AGA fetuses

Conditions

  • to Compare LIF Level in Cord Blood of Embryo's That Are IUGR to Those That Are AGA

Interventions

OTHER

blood sample and tissue sample

After birth and fetal umbilical cord disconnection, a blood sample will be taken from the umbilical cord (cord blood) of IUGR and of AGA fetuses (5cc) for cytokine ELISA testing. Also a small sample of the placenta will be examined in order to assess the level of ACTH protein in IUGR and AGA embryos

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02518126 on ClinicalTrials.gov